Search Results - "Oudejans, J J"

Molecular subtyping of male breast cancer by immunohistochemistry by Kornegoor, Robert, Verschuur-Maes, Anoek H J, Buerger, Horst, Hogenes, Marieke C H, de Bruin, Peter C, Oudejans, Joost J, van der Groep, Petra, Hinrichs, Bernd, van Diest, Paul J

“…Molecular subtyping of breast cancer by gene expression has proven its significance in females. Immunohistochemical surrogates have been used for this…”
Get full text

Immunohistochemical profiling based on Bcl-2, CD10 and MUMI expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma by MURIS, J. J. F, MEIJER, C. J. L. M, VOS, W, VAN KRIEKEN, J. H. J. M, JIWA, N. M, OSSENKOPPELE, G. J, OUDEJANS, J. J

Get full text

Frequent overexpression of aurora B kinase, a novel drug target, in non–small cell lung carcinoma patients by Vischioni, Barbara, Oudejans, Joost J, Vos, Wim, Rodriguez, Jose A, Giaccone, Giuseppe

“…The serine/threonine protein kinase aurora B, a key regulator of mitosis, is emerging as a novel drug target for cancer treatment. Aurora B overexpression has…”
Get full text

Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma by Kluin-Nelemans, H.C., van Marwijk Kooy, M., Lugtenburg, P.J., van Putten, W.L.J., Luten, M., Oudejans, J., van Imhoff, G.W.

“…The prognosis of T-cell lymphoma is poor. To explore the addition of the monoclonal antibody alemtuzumab, we studied the efficacy and tolerability of an…”
Get full text

Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier by Khalil, Ramzi, Boels, Margien G. S., van den Berg, Bernard M., Bruijn, Jan A., Rabelink, Ton J., Hogendoorn, Pancras C. W., Baelde, Hans J.

“…In this study, the effect of heterozygous germline mutations in the heparan sulfate (HS) glycosaminoglycan chain co-polymerases EXT1 and EXT2 on glomerular…”
Get full text

ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2 by Cillessen, Saskia A G M, Hijmering, Nathalie J, Moesbergen, Laura M, Vos, Wim, Verbrugge, Sue Ellen, Jansen, Gerrit, Visser, Otto J, Oudejans, Joost J, Meijer, Chris J L M

Get full text

Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B‐cell lymphomas by Muris, J. J. F., Ylstra, B., Cillessen, S. A. G. M., Ossenkoppele, G. J., Kluin‐Nelemans, J. C., Eijk, P. P., Nota, B., Tijssen, M., De Boer, W. P. H., Van De Wiel, M., Van Den Ijssel, P. R. L. A., Jansen, P., De Bruin, P. C., Van Krieken, J. H. J. M., Meijer, G. A., Meijer, C. J. L. M., Oudejans, J. J.

“…Summary Intrinsic resistance of lymphoma cells to apoptosis is a probable mechanism causing chemotherapy resistance and eventual fatal outcome in patients with…”
Get full text

Agreement on indication for systemic therapy between biopsied tissue and surgical excision specimens in breast cancer patients by Schmitz, Alexander M Th, Oudejans, Joost J, Gilhuijs, Kenneth G A

“…In breast cancer therapy, the indication for systemic therapy is typically based on prognostic markers from the surgical excision specimen. If such is…”
Get full text

Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors by JONG, K, MARCHIORI, E, OUDEJANS, J. J, MEIJER, G. A, CALDAS, C, YLSTRA, B, VAN DER VAART, A, CHIN, S.-F, CARVALHO, B, TIJSSEN, M, EIJK, P. P, VAN DEN IJSSEL, P, GRABSCH, H, QUIRKE, P

“…A series of studies have been published that evaluate the chromosomal copy number changes of different tumor classes using array comparative genomic…”
Get full text

ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects-a review by ten Berge, Rosita L, Oudejans, Joost J, Ossenkoppele, Gert J, Meijer, Chris JLM

“…Anaplastic large cell lymphoma (ALCL) can be divided into two major groups. The first is a spectrum of CD30+ T‐cell lymphoproliferative disorders including…”
Get full text

Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease by Dukers, D. F., Jaspars, L. H., Vos, W., Oudejans, J. J., Hayes, D., Cillessen, S., Middeldorp, J. M., Meijer, C. J. L. M.

“…Hodgkin's disease (HD) is a malignant lymphoproliferative disease characterized by the presence of Hodgkin–Reed–Sternberg cells surrounded by a reactive…”
Get full text

ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified by Ten Berge, R L, De Bruin, P C, Oudejans, J J, Ossenkoppele, G J, Van Der Valk, P, Meijer, C J L M

“…Aims:  Anaplastic large cell lymphoma (ALCL) is classically considered a clinicopathological entity separate from other nodal mature T‐cell lymphomas (TCL)…”
Get full text

Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease by Verbeek, Wieke H.M, Goerres, Marije S, von Blomberg, B. Mary E, Oudejans, Joost J, Scholten, Petra E.T, Hadithi, Muhammed, Al-Toma, Abdul, Schreurs, Marco W.J, Mulder, Chris J.J

“…Abstract Background: Refractory celiac disease (RCD) patients with aberrant, often clonal, intraepithelial T-cells are at high risk for development of…”
Get full text

Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma by VAN HOUDT, Inge S, OUDEJANS, Joost J, MEIJER, Chris J. L. M, KUMMER, Jean A, VAN DEN EERTWEGH, Alfonsus J. M, BAARS, Arnold, VOS, Wim, BLADERGROEN, Bellinda A, RIMOLDI, Donata, MURIS, Jettie J. F, HOOIJBERG, Erik, GUNDY, Chad M

“…Purpose: There have been reports of successful treatment of metastatic melanoma patients with active specific immunotherapy (ASI) using irradiated autologous…”
Get full text

Molecular Detection and Genotyping of Male-Specific Coliphages by Reverse Transcription-PCR and Reverse Line Blot Hybridization by VINJE, Jan, OUDEJANS, Sjon J. G, STEWART, Jill R, SOBSEY, Mark D, LONG, Sharon C

“…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas by MURIS, J. J. F, MEIJER, Cjlm, OSSENKOPPELE, G. J, OUDEJANS, J. J, CILLESSEN, Sagm, VOS, W, KUMMER, J. A, BLADERGROEN, B. A, BOGMAN, Mjjt, MACKENZIE, M. A, JIWA, N. M, SIEGENBEEK VAN HEUKELOM, L. H

“…Clinical outcome in diffuse large B-cell lymphoma (DLBCL) remains unpredictable, despite the identification of clinical prognostic parameters. Here, we…”
Get full text

Activated Intrinsic Apoptosis Pathway Is a Key Related Prognostic Parameter in Acute Myeloid Leukemia by HESS, Corine J, BERKHOF, Johannes, DENKERS, Fedor, OSSENKOPPELE, Gert J, SCHOUTEN, Jan P, OUDEJANS, Joost J, WAISFISZ, Quinten, SCHUURHUIS, Gerrit J

“…By parallel assessment of multiple apoptosis-related transcripts, we aimed to refine the current concept of apoptosis resistance in acute myeloid leukemia…”
Get full text

Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma by van Galen, JC, Hoefnagel, JJ, Vermeer, MH, Willemze, R, Dijkman, R, Tensen, CP, de Boer, WPH, Meijer, CJ, Oudejans, JJ

“…Two distinct primary cutaneous large B cell lymphomas are recognized: primary cutaneous follicle centre lymphoma (PCFCL), characterized by an excellent…”
Get full text

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma by Müschen, M, Rajewsky, K, Bräuninger, A, Baur, A S, Oudejans, J J, Roers, A, Hansmann, M L, Küppers, R

“…Recent work identified Hodgkin and Reed-Sternberg (H/RS) cells in classical Hodgkin's disease (cHD) as clonal progeny of mature B cells. Therefore, it is…”
Get full text

Activity-based differentiation of pathologists’ workload in surgical pathology by Meijer, G. A., Oudejans, J. J., Koevoets, J. J. M., Meijer, C. J. L. M.

“…Adequate budget control in pathology practice requires accurate allocation of resources. Any changes in types and numbers of specimens handled or protocols…”
Get full text